不良研究所

The teaching hospital network of 不良研究所 is an integral part of the research, teaching, and clinical activities of the Faculty of Medicine and Health Sciences. By agreement and tradition, the administration, medical staff, and scientific personnel of these institutions are closely integrated with 不良研究所 and form the basis for the clinical departments of the Faculty of Medicine and Health Sciences. The 不良研究所 Health Centre (MUHC) / Centre universitaire de sant茅 不良研究所 (CUSM) is a merger of seven teaching hospitals affiliated with the Faculty of Medicine and Health Sciences at 不良研究所.

The 不良研究所 Health Centre (MUHC) offers specialized and multidisciplinary tertiary and quaternary care of exceptional quality focused on the needs of adult and pediatric patients, in a bilingual environment, making it one of the most comprehensive teaching hospitals in North America. Every year, the MUHC receives more than 539,891 ambulatory visits; admits over 34,280 inpatients; performs more than 28,566 surgeries; and delivers almost 2,997 babies yearly.

Affiliated with the Faculty of Medicine and Health Sciences of 不良研究所, the MUHC contributes to the evolution of medicine by attracting clinical and scientific experts from around the world, evaluating cutting-edge medical technologies, and training tomorrow's healthcare professionals.

Our activities are carried out at the following locations:

• Montreal Children's Hospital, Royal Victoria Hospital, Montreal Chest Institute, and Cedars Cancer Centre at the Glen Site
• 1001 Decarie Boulevard
• Montreal QC H4A 3J1
• Telephone: 514-934-1934
• Website:

• Montreal General Hospital
• 1650 Cedar Avenue
• Montreal QC H3G 1A4
• Telephone: 514-934-1934
• Website:

• Montreal Neurological Institute and Hospital
• 3801 University Street
• Montreal QC H3A 2B4
• Telephone: 514-398-6644
• Website:

• Lachine Hospital
• 650 16th Avenue
• Lachine QC H8S 3N5
• Telephone: 514-934-1934
• Website:

The MUHC is a community of more than 16,000 people working within the organization's seven clinical missions: Medicine, Surgery, Neurosciences, Mental Health, Women's Health, Cancer Care and the Montreal Children's Hospital. In 2021鈥�2022, our workforce comprised 3,825 nurses licensed practical nurses and orderlies; 2,125 health professionals other than physicians and nurses (includes some residents and technicians); 3,287 researchers, investigators, students, post-doctoral fellows, and other members of the Research Institute of the MUHC (RI-MUHC); 1,457 physicians; 76 dentists; 118 pharmacists; 328 managers; 2,357 office staff; 2,560 other professionals; 684 active volunteers.

In addition to our clinical expertise, we are proud of the quality and rigour of our clinical and scientific training. All MUHC physicians are appointed professors at the Faculty of Medicine and Health Sciences at 不良研究所. Each year, we welcome around 3,400 students and interns from university and college levels, as well as from professional schools. In 2020鈥�2021, there were 1,803 nursing students, 759 medical students, 695 adult and pediatric medical residents,153 adult and pediatric medical fellows, 18 general medicine residents in adult and pediatric dentistry, and 1 adult oral and maxillofacial surgery resident.

The Research Institute of the 不良研究所 Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The Institute, which is affiliated with the Faculty of Medicine and Health Sciences of 不良研究所, supports more than 500 researchers and nearly 1,472 research trainees devoted to a broad spectrum of fundamental, clinical, and evaluative research at the Glen site and the Montreal General Hospital. Its research facilities provide a dynamic multidisciplinary research environment that fosters collaboration and leverages discoveries aimed at improving the health of patients across their lifespan. The RI-MUHC is supported in part by the Fonds de recherche du Qu茅bec - Sant茅 (FRQS). More information is available at .

The MUHC acts as the server laboratory for the Montreal-multi-institutional cluster of OPTILAB. In addition to the MUHC, the cluster includes laboratories in the CIUSSS du Centre-Ouest-de-l'脦le-de-Montr茅al, the CIUSSS de l'Ouest-de-l'脦le-de-Montr茅al and the CISSS de l'Abitibi-T茅miscamingue.

In 2015, the MUHC brought together our legacy sites鈥攖he Royal Victoria Hospital, the Montreal Children's Hospital, the Montreal Chest Institute, and the Cedars Cancer Centre鈥攐nto one site: the Glen. At the Glen site, our vision of excellence is taking shape by integrating healthcare, research and teaching on a whole new level. With custom-built facilities, state-of-the-art equipment, and nurturing healing environments, we are pushing the boundaries of innovation for our current generation and those to come. Renovations are also underway at our other MUHC sites鈥攖he Montreal General Hospital, the Montreal Neurological Hospital and the Lachine Hospital鈥攁s we continue to strive to provide the best care for life for our patients and families.

For more information on the MUHC, visit .

There are three other principal teaching hospitals:

Jewish General Hospital (a member facility of the Integrated Health and Social Services University Network for West-Central Montreal / Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS) du Centre-Ouest-de-l'脦le-de-Montr茅al)

• 3755 C么te Ste-Catherine Road
• Montreal QC H3T 1E2
• Telephone: 514-340-8222
• Website:

Since 1934, the Jewish General Hospital has served patients鈥攐f diverse religious, linguistic, and cultural backgrounds鈥攚ho reside in Montreal, elsewhere in Quebec, and beyond. As one of the province's largest acute-care hospitals, this 637-bed 不良研究所 teaching hospital admits more than 22,000 patients per year, while handling approximately 578,000 outpatient visits; more than 84,000 emergency visits; and more than 3,600 births. The JGH is widely recognized for excellence in various specialties, including oncology at the Segal Cancer Centre, cardiology, neonatology, orthopedics, family medicine, aging, and emergency medicine. In addition, several services鈥攊ncluding the Emergency Department, Intensive Care, Neonatal Intensive Care, Coronary Care, and the operating rooms鈥攐pened in a new critical-care pavilion in 2016. The hospital has been designated by the government of Quebec as one of Montreal's five major service centres, as a provincial centre for high-risk obstetrical and neonatal care, and as a breast referral and investigation centre. In addition, during the COVID-19 pandemic, the JGH played a leading role in treatment and care, having been designated by the provincial government in early 2020 as one of the first healthcare centres to provide in-patient treatment to adults who were ill with the virus.

Treatment is provided by approximately 850 affiliated doctors, many of whom have teaching appointments at 不良研究所, as well as more than 300 medical residents per year, together with nursing and a wide range of allied health services. The Jewish General Hospital carries out more than 22% of the training for 不良研究所's Faculty of Medicine and Health Sciences and is home to several of the University's programs, including the 不良研究所 Centre for Viral Diseases (encompassing research formerly conducted by the 不良研究所 AIDS Centre), the 不良研究所 Centre for Translational Research in Cancer, the 不良研究所 Head and Neck Surgery and Oncology Program, and the 不良研究所 Menopause Clinic.

The hospital's is acknowledged as a world leader in many fields of research, including cancer (the Terry Fox Molecular Oncology Group), aging (the Bloomfield Centre for Studies in Aging), epidemiology (the Centre for Clinical Epidemiology and Community Studies), nursing (the Centre for Nursing Research), cardiovascular disease, genetics, emergency medicine, nephrology, and the psychosocial aspects of illness. The outstanding quality of this work has enabled the Lady Davis Institute to rank among the leaders of Quebec鈥檚 hospital-affiliated research institutions in attracting high levels of funding per researcher.

More information is available at .

St. Mary's Hospital Center (Montreal West Island Integrated University Health and Social Services Centre/Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS) de l'Ouest-de-l'脦le-de-Montr茅al)

• 3830 Lacombe Avenue
• Montreal QC H3T 1M5
• Telephone: 514-345-3511

St. Mary's Hospital Center (SMHC) is an acute-care specialized 不良研究所 affiliated teaching hospital with 273 adult beds. Its official designation as a university-affiliated teaching hospital or a CHAU (Centre hospitalier affili茅 universitaire) further reinforces its commitment and ability to deliver high quality health care while playing a leading role in the areas of teaching and research. It is responsible for the training of a large cohort of undergraduate and post-graduate students in Medicine and the allied health disciplines.

In 2021鈥�2022, over 3,400 babies were delivered at St. Mary's, which is the first hospital in Montreal to have received the World Health Organization's (WHO) international recognition of Baby Friendly Hospital Status by the Quebec ministry of health. St. Mary's also has a progressive and active Family Medicine Centre recognized for its teaching. The Hospital also provides numerous highly specialized services such as renal dialysis, oncology, geriatric assessment, and psycho-geriatric, nuclear medicine, C.T. scanning services, as well as MRI exams. There are more than 94,960 out-patient clinic visits; 8,672 procedures through the surgical day centre, and over 13,459 patient admissions, in addition to ambulatory care visits, annually. The Hospital is noted for its devotion to patients, motivation toward the achievement of excellence, and compassionate care.

St Mary's Research Centre is embedded in St Mary's Hospital Center. Visit the to learn more.

Douglas Mental Health University Institute (Montreal West Island Integrated University Health and Social Services Centre /Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS) de l'Ouest-de-l'脦le-de-Montr茅al)

• 6875 LaSalle Boulevard
• Montreal QC H4H 1R3
• Telephone: 514-761-6131
• Website:

Founded in 1881, the Douglas Mental Health University Institute has a triple mission of care, research, and teaching. A member of the 不良研究所 Integrated University Health and Social Services Network (RUISSS 不良研究所) and affiliated with the World Health Organization, it offers hospitalization and extensive out-patient services.

The hospital provides child and adolescent, adult, and geriatric clinical services, and is dedicated to treating patients in the least restrictive manner possible, with a major focus on rehabilitation and successful reintegration into the community. It offers training for residents in psychiatry, as well as for medical and paramedical students from a wide range of disciplines. There are more than 113,000 interventions carried out annually in all programs combined.

The Douglas Institute is one of the largest research centres in mental health in the country, with a team of 70 scientists and clinical researchers and more than 250 university students. This team is devoted to making better sense of the causes of mental disorders鈥攚hether genetic, environmental, cultural, or social鈥攁s well as developing diagnostic tools, treatments, and prevention methods.

The Douglas Research Centre is also home to 不良研究所 centres in schizophrenia, aging, and suicide, as well as the Montreal Pan American Health Organization/World Health Organization Collaborating Centre for Reference and Training in Mental Health, which offers consultation services, research, and teaching programs here and abroad.

Visit the to learn more.

As part of the Quebec Government鈥檚 health care reform in 2015, most health care institutions merged and grouped into larger entities called either a Centre int茅gr茅 universitaire de sant茅 et de services sociaux (CIUSSS), or a Centre int茅gr茅 de sant茅 et de services sociaux (CISSS). In general, contracts of affiliation are no longer between individual hospitals and the University but between these larger entities and the University.

The following institutions have contracts of affiliation with 不良研究所 for participation in teaching and research in one or more departments and services:

• 不良研究所 Health Centre

• CIUSSS de l'Ouest-de-l鈥櫭巐e-de-Montr茅al

• CIUSSS du Centre-Ouest-de-l鈥櫭巐e-de-Montr茅al

• CISSS de l'Outaouais

• CISSS de Laval

• Shriners Hospitals for Children - Canada

• Lyman Duff Medical Building
• 3775 University Street, Suite 100
• Montreal QC H3A 2B4
• Telephone: 514-398-8975
• Fax: 514-398-8121
• Website: mcgill.ca/painresearch

Founded in 2003, the Alan Edwards Centre for Research on Pain at 不良研究所 is one of the top pain research centres in the world. The Centre comprises over 40 clinical and fundamental researchers from the Faculties of Medicine and Health Sciences, Dental Medicine and Oral Health Sciences, and Science. Its main goal is to bring together the 不良研究所 community of basic and clinical pain researchers to promote interdisciplinary research that will breach the traditional silos and result in cures for persons suffering from chronic pain. Through world-class educational and community outreach activities, cutting-edge research activities, and international collaborations, the Centre focuses on new discoveries and their clinical applications to improve the prevention and treatment of chronic pain.

• McIntyre Medical Sciences Building, Room 1002/1004
• 3655 Promenade Sir-William-Osler
• Montreal QC H3G 1Y6
• Telephone: 514-398-3512/3514
• Fax: 514-398-7452
• Website:

This centre concentrates on interdisciplinary research on artificial cells first invented here (Chang, 不良研究所,1957, Science 1964) and since evolved into micro-nano systems; nanomedicine; nanobiotherapeutics; nanobiotechnology; nanotechnology; blood substitutes based on nanobiotechnology; hebiannualmoperfusion; bioencapsulation of enzymes, cells, stem cells, probiotics; regenerative medicine; delivery systems for drug, enzymes, genes, etc.

At present, the members of this centre at 不良研究所 come from different specialties: Physiology, Biomedical Engineering, Medicine, Pathology, Surgery, Bioengineering, Biotechnology, and Chemical Engineering. This is an international centre with 2 international societies, which coordinates biannual meetings around the world. It is the emeritus editor's office for the international journal Artificial Cells, Nanomedicine, and Biotechnology (2020-) and Editor's Office for a book series titled Regenerative Medicine, Artificial Cells, and Nanomedicine. It is also the office of the Honorary president and coordinator of the International Network of Artificial Cells, Blood Substitutes and Biotechnology.

This is a public service website with reviews, papers, videos, books, and monographs, all complimentary from the director. It is the major international reference source in this area.

• The Research Institute, MUHC Glen Site
• 1001 Decarie Blvd.,E-M0.3509
• Montreal QC H4A 3J1
• Telephone: 514-207-9887
• Website: mcgill.ca/crrd

The Centre for Research in Reproduction and Development (CRRD), originally established as the Centre for the Study of Reproduction in 1982, is among the longest-standing research centres at 不良研究所 and was a founding partner of the FQRNT-funded R茅seau Qu茅becois en Reproduction (RQR). Today, the interdepartmental and interdisciplinary CRRD is home to more than 30 principal investigators, 70 graduate students, 50 fellows and research associates, and 30 technical support staff from 15 departments, 4 faculties, and 8 divisions at the University. With such critical mass, the CRRD has established itself as one of the most productive and dynamic research hubs for young and established researchers committed to the science of reproduction and development.

The research programs of our members span a wide range of diverse and complementary topics, including understanding the basic biological mechanisms that control developing eggs and sperm within the gonads, how the reproductive hormones are produced and exert their effects, how the developing embryo implants into the uterus and establishes communication with its mother, causes and cures for conditions such as pre-eclampsia and intra-uterine growth retardation, and the effects of environmental pollutants and disease on the development of the eggs and sperm and of the fetus. We use both animal model systems and human clinical studies to reach our research objectives.

The CRRD enables and promotes interactions between investigators at 不良研究所, other universities in Quebec, across Canada, and internationally.

• 3640 rue de la Montagne
• Montreal QC H3G 2A8
• Telephone: 514-398-6962
• Website:

The Centre for Research on Brain, Language and Music (CRBLM) at 不良研究所 is a Regroupement Strat茅gique whose mission is to promote research and training in the areas of language and music neuroscience, performance, and development. Participating universities include 不良研究所, Universit茅 de Montr茅al, UQAM, and Concordia. Our infrastructure for language and music research is unparalleled, including research facilities located in the 不良研究所 Faculties of Medicine and Health Sciences, Science, Arts, and Education, as well as the International Laboratory for Brain and Music Research (BRAMS) located at the Universit茅 de Montr茅al. Our specific objectives include:

1. promoting the scientific study of language and music neuroscience, performance, and development;
2. stimulating interdisciplinary and cross-domain collaboration among researchers on basic and applied problems in language and music;
3. fostering innovative research training for graduate and postdoctoral students;
4. disseminating research findings to clinical and educational end-users;
5. forming national and international partnerships.

Our goal is to develop a fundamental theoretical, behavioral, and neuroscientific understanding of the neurobiological, social, and communicative processes of language and music.

• 3801 University Street, Basement
• Montreal QC H3A 2B4
• Email: info [at] ludmercentre.ca
• Website:

The Ludmer Centre for Neuroinformatics & Mental Health advances multi-omics, big-data research in normal and abnormal brain development鈥攏eurological and psychiatric. It is a collaboration between 不良研究所, the Douglas Mental Health University Institute (The Douglas), the Jewish General Hospital鈥檚 Lady Davis Institute (JGH/LDI), and Montreal Neurological Institute-Hospital (The Neuro).

The Centre encompasses researchers, their labs and trainees, based in the 不良研究所 faculties of Science and Medicine and Health Sciences, and their three hospitals' partners (The Douglas, JGH, The Neuro), and

• Develops innovative, interoperable and open-source neuroinformatics infrastructure.
• Leads and supports the application of largescale big-data approaches to brain research.
• Mentors and trains transdisciplinary researchers in the application of big-data research.

  leads the Neuroimaging and Neuroinformatics Pillars (the 不良研究所 Centre for Integrative Neuroscience-MCIN) at The Neuro. A James 不良研究所 Professor of Neurology & Neurosurgery, he is the Scientific Director of three 不良研究所-led transdisciplinary initiatives: the , , and Healthy Brains, Healthy Lives.

  leads the Genomics, Bioinformatics & Statistical Genetics Pillar. She is a James 不良研究所 Professor in the departments of Oncology, Human Genetics & Epidemiology; Biostatistics & Occupational Health; and the Division of Cancer Epidemiology; and the Graduate Program Director of the Ludmer-supported Quantitative Life Sciences (QLS) PhD program at 不良研究所.

  leads the Genomic & Epigenetics Pillar. She is an Assistant Professor in the Department of Psychiatry at 不良研究所 and Leads the Environmental Adversity, Neurodevelopment and Mental Health research group at the Douglas Mental Health University Institute. Dr. Silveira is a member of the National Scientific Council on the Developing Child at the Harvard School of Medicine.

The Ludmer Centre Single-Cell Brain Initiative gift donated in November 2022 by the Ludmer Foundation is the next chapter in a legacy of excellence.

The Centre will support these initiatives with their three partners:

To learn more, or participate in a .

• Montreal General Hospital, Livingston Hall, L7 132
• Research Institute of the 不良研究所 Health Centre
• 1650 Cedar Avenue
• Montreal QC H3G 1A4
• Telephone: 514-934-8094
• Fax: 514-934-8216
• Website: mcgill.ca/crn

The 不良研究所 Centre for Research in Neuroscience (CRN), which was officially established as a University Centre in 1986 under the leadership of Dr. Albert Aguayo, is a vibrant research centre that brings together basic and clinical scientists in highly interactive research groups.

The CRN has been and remains home to some of Canada鈥檚 most distinguished neuroscientists. We number more than 60 trainees and staff at any time, including postdoctoral researchers, graduate students, undergraduates, and technicians. The CRN offers a program to train pre-doctoral students for an M.Sc. or Ph.D. degree, as well as postdoctoral Ph.D. or M.D. graduates for careers in biomedical research.

• Lady Davis Institute for Medical Research
• Jewish General Hospital
• 3755 C么te Ste-Catherine
• Montreal QC H3T 1E2
• Telephone: 514-340-8222 ext. 28873
• Website: mcgill.ca/translational-research-cancer

The great challenge faced by the oncology research community is the translation of laboratory and clinical research data into clinical outcomes of benefit in the assessment, treatment and prevention of cancer. Established in 1996, thanks to a generous endowment gift from the Goldfarb Family Foundation and the Alexander Family Foundation, the MCTRC aims to facilitate the translation of the exciting novel findings from fundamental research laboratories into testable hypotheses for evaluation in clinical trials in oncology (bench-to bedside translation).

The Centre provides the infrastructure to bring fundamental and clinician researchers together in order to synergize their efforts at generating novel and promising translational research. This provides a structured focus for these activities and accelerates the testing of potential benefits derived from scientific discovery. Over the years, the MCTRC researchers have been key in discovering, testing and translating new treatment options and diagnostic markers that leads to new cancer management guidelines, and improving cancer care to Canadians.

The Centre also provides a high quality environment for training clinician-scientists in cancer research. Trainees include both graduate students (M.Sc. and Ph.D. students) from the departments of Experimental Medicine, Human Genetics, Pharmacology & Therapeutics, and Pathology) and M.D. scientists interested in clinically-relevant cancer research.

The unique interaction of clinician-scientists and Ph.D. researchers provides an important strength to novel therapeutic development programs. As part of the Segal Cancer Centre located at the Jewish General Hospital, the MCTRC has been forging partnerships with other provincial (iTMT, QCC, Q-CROC) national (Exactis, MoH-CCN) and international (CCC19 and WIN Consortia) research groups as part of its commitment to conducting cutting-edge fundamental, translational and clinical research in cancer and providing training for the next generation of cancer researchers.

• Lady Davis Institute, Room F-318
• Jewish General Hospital
• 3999 C么te Ste-Catherine
• Montreal QC H3T 1E2
• Telephone: 514-340-8260
• Contact: mcvd_admin.fmhs [at] mcgill.ca ( )
• Website: mcgill.ca/mcvd/

The 不良研究所 Centre for Viral Diseases (MCVD) was established in 2020 following the transformation of the 不良研究所 AIDS Centre. Its mission is to provide solutions to public-threatening viral diseases by advancing research, education, and patient care through inter-disciplinary efforts.

Members of MCVD have built world-class research programs in basic virology, immunology, drug discovery, epidemiology, population health and clinical research. They focus on major viral diseases including HIV/AIDS, chronic viral infections and cancer, influenza, COVID-19, emerging and re-emerging viral infections. They are also dedicated to training the next-generation of healthcare professionals and researchers with the ultimate goal of strengthening and growing our capacity of investigating and controlling viral diseases, as well as preparing for future viral pandemics.

Dr. Chen Liang is the Centre's inaugural Director. He took the role of the Interim Director of the 不良研究所 AIDS Centre in 2018, and led the efforts of launching the 不良研究所 Centre for Viral Diseases. The leadership of the MCVD also includes Dr. Marina Klein, Associate Director for Clinical Research, and Dr. Andrew Mouland, Associate Director for Basic Research ( mcgill.ca/mcvd/about-us/leadership). Ms Elisa Xu is the Centre's coordinator.

• Research Institute of the 不良研究所 Health Centre
• 5252 de Maisonneuve West, Room 3D.58
• Montreal, Quebec, Canada
• H4A 3S5
• Telephone: 514-934-1934, ext. 32128
• Fax: 514-484-1424
• Website: mcgill.ca/tb

Founded in 2014, the 不良研究所 International TB Centre, a WHO Collaborating Centre for TB Research, is a world leader in the interdisciplinary study of TB.

Our TB Centre aims to make a positive contribution to ending the TB epidemic in Canada and globally, especially in high-burden countries and among the most vulnerable population groups, through interdisciplinary research, training and capacity building and equitable research partnerships.

Our Centre brings together 37 investigators (27 members from 不良研究所 and the RI-MUHC and 10 associate members) who have research expertise spanning from basic biomedical methods to clinical, epidemiological and social sciences. Members work includes the development, evaluation and implementation of new diagnostic tests and strategies, as well as new treatment regimens for TB infection and disease. Our Centre also includes 7 International Community Advisory Board members (5 TB survivors and 2 people in charge of the coordination).

Please visit our website at mcgill.ca/tb.

• 6825 boulevard LaSalle
• Verdun QC H4H 1R3
• Telephone: 514-766-2010
• Website:

The 不良研究所 Research Centre for Studies in Aging (MCSA) is committed to investigating causes and possible treatments of the dementias, especially Alzheimer's Disease. Established in 1985 to develop and offer specialized services for the elderly, MCSA has grown into a multi-disciplinary academic unit dedicated to gerontological research and postgraduate teaching. The MCSA research scope is broad, encompassing mechanisms of aging as well as prevention of age-associated disorders. Since its inception, the MCSA remains dedicated to transformative research and counts numerous teaching, public education, and research accomplishments. The Centre has achieved international recognition and outreach, continuously attracting students, young scientists and international collaborators in Alzheimer鈥檚 Disease research. The Centre鈥檚 scientific production and visibility through many highly cited contributions attest to its excellence and world-class research positioning.

During the past decades, the MCSA has played a pioneering role in identifying genetic abnormalities leading to an increased risk for Alzheimer's Disease. The Memory Clinic of the Alzheimer's Disease Research Unit, developed by Professor Emeritus Dr. Serge Gauthier, continues to focus on improved therapies, long-term treatment of subjects affected by dementia, and enhancing the quality of life of patients and caregivers. Over the last 37 years the priority of the MCSA evolved to primary prevention of cognitive decline, early diagnosis, and treatment for persons with mild or prodromal symptoms, and best treatments for patients with various types of dementia. The importance of genes such as ApoE as risk factors and as predictors of response to treatment in Alzheimer鈥檚 Disease was one of the significant contributions of the MCSA to the field of aging. Another achievement of the MCSA is the strong link with academic research centres worldwide, including Brazil, China, and Germany, which is reflected by a steady flow of students and visiting scholars from these countries, among others.

In Canada, the MCSA created the academic trial network C5R and has hosted consensus meetings on the best evidence-based approach to the diagnosis and management of various types of dementia. The current focus of the MCSA is on prevention, and the development of tools and methods to allow earliest diagnosis and intervention of age-related disease. Prevention has been identified as an important objective in dementia research by national and international institutes (Alzheimer Society of Canada, National Institute of Aging USA) and is a priority of 不良研究所 over the next decade. The MCSA contributes to this effort with its Dementia Prevention Program that was launched in 2012, entitled 鈥淧revention of Neurodegenerative Disease in Everyone at Risk鈥� (P.O.N.D.E.R.). This program was rebranded in 2020 and is now called SNAP, 鈥淪creening of Neurobehavioural Abnormalities in the Aging Population.鈥� SNAP, aims to characterize both normal aging and disease, as well as risk and protective factors. SNAP still aims at utilizing cognitive performance as a tool to screen for dementia at early stages. SNAP features a website that provides free online cognitive assessments and encompasses a comprehensive approach towards the study of variables associated with neurodegeneration in the elderly population. The website is currently available for participants! To register and play the free cognitive training games, please visit: (under construction until 2023).

The MCSA has established a computational infrastructure devoted for teaching neuroimaging in dementia for fellows, graduate, and postdoctoral students. This infrastructure program is under the direction of Dr. Pedro Rosa-Neto, M.D., Ph.D. The Translational Neuroimaging Laboratory at the MCSA aims to understand how toxic proteins cause brain damage in Alzheimer鈥檚 Disease patients. We also develop novel methodologies for early detection of these toxic proteins in the persons without symptoms (refer to the ). Research in the field of neuroimaging has been focusing on the early detection of dementia, and AD prevention. Our clinic collaborates with other experts at 不良研究所 using the most advanced and sensitive Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) protocols to evaluate patients with mild cognitive complaints. The PET and MRI technologies, combined with our clinical expertise, allow for early diagnosis and appropriate treatment of the condition causing memory deficits.

Other MCSA Projects:

TRIAD: Translational Biomarkers in Aging and Dementia (Pavilion Crossroads)

The Translational Biomarkers in Aging and Dementia (TRIAD) is a longitudinal observational cohort specifically designed to study mechanisms driving dementia. The TRIAD cohort focuses on advanced personalized and preclinical dementia diagnosis. We study dementia markers and their progression from pre-symptomatic stages to the onset of the Alzheimer鈥檚 disease or other types of dementia. The TRIAD cohort assesses the trajectory of multiple imaging and fluid biomarkers in clinical populations and serves as a benchmark for testing novel biomarkers of dementia. For information, please visit: .

International Dementia Conference Series (IDC)

The scope of the International Dementia Conference Series (IDC) is to promote exchanges between students/trainees and established scientists in the field of Dementia. It is a space for scientists from around the world and is aimed at facilitating collaborative endeavors through the discussion of the works presented. These presentations constitute the frontiers of knowledge in Dementia research and promote the cultivation of new ideas and directions to pursue. This series also aims to embody the translational nature of research by bringing together specialists in in vitro studies focused on understanding individual biological constituents of disease, in vivo studies whereby these individual constituents are studied in the context of model organisms of disease, and in clinical studies where we find emergence of these constituents in humans affected by disease. This level of communication across the hierarchy of research environments will be a crucial component towards finding lasting solutions. For information, please visit .

Young Caregiver groups

The 不良研究所 Research Centre for Studies in Aging is pleased to announce that in September 2022, two support groups were created for the children of patients with major neurocognitive disorders before the age of 65, such as early-onset Alzheimer's disease. This is the first initiative of its kind in Quebec. Given the rarity of their situation, few services are available to them. MCSA wishes to offer this population information and a non-judgmental space where they can share their story to contribute to the democratization of this important but unknown role. For further information, including our conference series entitled: 鈥淓nsemble, Nous Prenons Soins.鈥�, please contact mallery.landry [at] affiliate.mcgill.ca.

Brainy Boomers Lecture Series

In 2007 the MCSA Education Committee established the 鈥淏rainy Boomer Lecture Series鈥� in order to support its objectives, raise awareness and educate the community at large. These public series are presented by academic professionals and medical specialists and the goal of the series is to suggest and initiate practical steps to improve brain health, to prevent other age-related disorders and to promote healthy lifestyle choices for our senior population. Topics include Successful Aging, Exercise for Seniors, and Culinary Cooking Classes. For lectures, please visit the . For further information (registration free), please email us at brainy.boomer-mcsa [at] mcgill.ca.

• Lady Meredith House
• 1110 Pine Avenue West, Room 205
• Montreal QC H3A 1A3
• Telephone: 514-398-4987
• Fax: 514-398-7246
• Website: mcgill.ca/ihse

The Institute of Health Sciences Education (IHSE) opened its doors in 2019 and builds upon the historic legacy of the Centre for Medical Education which originated in 1975. The Institute promotes excellence in research and practice across the continuum of health sciences education. Health sciences education encompasses medical education, health professions education, and biomedical sciences education, amongst other domains of concern.

With an active interest in the advancement and transformation of health sciences education and practice, members of the IHSE consist of researchers, educators, clinicians, and graduate students from diverse backgrounds and disciplines. Bringing together research and practice, this unique mix of individuals investigate important educational questions, and move beyond traditional departmental and disciplinary boundaries to create new knowledge, enable capacity-building, and promote knowledge translation in the field.

The Institute of Health Sciences Education offers a variety of educational opportunities for health professions practitioners, educators, students, residents, and faculty.

1. The Graduate Certificate Program in Foundations of Health Sciences Education is an interdisciplinary blended distance learning program where learners gain knowledge of current education theories as well as the expertise to apply this knowledge in health sciences curriculum design, instruction, assessment, and program evaluation. Participants will also learn to apply concepts of educational leadership, scholarship and research design across a range of educational settings.
2. The Scholarship in Medical and Health Sciences Education program is designed for medical and health sciences students and residents who are interested in developing capabilities related to educational research. Participants will develop, or participate in a project in progress, that applies educational theories and methodologies, to an educational research question.
3. The Foundations in Medical and Health Sciences Education program, a non-clinical elective offered on an annual basis in Period 6 of the rotation schedule, which generally falls between November-December of the calendar year. The elective is intended to expose students and residents to the field of medical and health sciences education through interactive lectures, group discussions, individual and group projects, and participation in the activities of the Institute of Health Sciences Education.

4. The new 4-year PhD program in Health Sciences Education is designed for individuals eager to develop expertise in research, educational scholarship, knowledge translation (including written and oral communication), leadership, research mentoring, capacity and career building, and grant writing. The program aims to: advance societal health and well-being, and the quality and safety of patient care; promote teaching in health care of the highest possible quality; advance the field of health sciences education research; and contribute to building and sustaining a vibrant, inter-disciplinary, inter-professional, and practice-informed community

For more information, visit: the IHSE website.

• 1160 Pine Avenue West
• Montreal QC H3A 1A3
• Telephone: 514-398-3535
• Fax: 514-398-6769
• Website: mcgill.ca/gci

The Rosalind and Morris Goodman Cancer Institute, affiliated with 不良研究所鈥檚 Faculty of Medicine and Health Sciences, is a recognized world-class research institute contributing to innovative developments in the treatment and ultimately the cure for cancer. Our scientists and clinician scientists are tackling the most challenging problems in cancer research through a multidisciplinary approach, supported by world-leading Innovation Platforms and a dedicated staff of research and administrative professionals. The mission of the Institute is to understand what drives cancer in order to better prevent, diagnose, and treat the disease.

The Rosalind and Morris Goodman Cancer Institute provides an internationally recognized training ground for the next generation of investigators who will pursue research in the life sciences and cancer. The Institute plays a key role in reaching out and educating the public on the fundamentals of cancer research and understanding the causes of cancer, its prognosis, and its treatment.

Further information is available at the Institute's website.

• 3801 University Street
• Montreal, Quebec, Canada H3A 2B4
• Telephone: 514-398-6644
• Website: mcgill.ca/neuro

The Neuro (Montreal Neurological Institute-Hospital) is a world-leading Open Science institute dedicated to brain/neuroscience research, training, and advanced patient care. The Montreal Neurological Institute is a 不良研究所 research and teaching institute. The Montreal Neurological Hospital is part of the Neuroscience Mission of the 不良研究所 Health Centre.

Founded in 1934 by neurosurgeon Dr. Wilder Penfield, The Neuro is the largest specialized neuroscience research and clinical centre in Canada, and one of the largest in the world. Our mission is to understand the brain, find cures and effectively treat people with neurological disorders. We believe our Open Science practice and tools will accelerate scientific progress towards solving the most persistent problems in neuroscience, to accelerate discovery, and impact the lives of millions of patients around the world. The Neuro delivers exceptional care to thousands of patients and is a critical referral centre (for Quebec, Canada) for the most difficult neurological conditions /disorders and for patients lacking definitive diagnoses. Each year, there are more than 37,000 ambulatory visits to The Neuro, over 2,500 patients admitted, and more than 70,000 diagnostic and interventional procedures (angiograms, CT, EEG, EMG, MRI, etc.) and 1,800 surgeries performed.

The Neuro鈥檚 scientists and clinicians are pushing the frontiers of science and medicine. They have pioneered surgical treatments of epilepsy and developed electroencephalography as a tool to diagnose seizure activity. The Neuro is the home of many famous neuroscientists including Brenda Milner, Herbert Jasper, KAC Elliot, Robert Zatorre, Alan Evans, Guy Rouleau, and many others. The Neuro鈥檚 McConnell Brain Imaging Centre (BIC) is one of the top three brain imaging centres in the world pioneering multimodal imaging, large open reference data sets and introducing brain imaging to Canada: Computer Tomography (CT) (1973), Positron Emission Tomography (PET) (1975), Magnetic Resonance Imaging (MRI) (1985), and whole body 7T MRI (2019).

The Neuro strives to adopt the newest technologies and recruit the best scientists, trained at the world鈥檚 leading research centres. Through Open Science, it is now at the vanguard of brain science: transparent, fast, and global flow of knowledge, where discoveries made on one continent can instantly amplify those on another, and where patients benefit from discoveries that represent the most advanced research taking place around the world.

The Neuro is the largest training centre for neuroscience in Canada, with over 250 postdoctoral fellows, residents, and graduate students working in the labs and clinics each year.

The Neuro faculty members are collaborative and lead international research teams that generate fundamental information that spans the full spectrum of neuroscience from cell and molecular biology and neurophysiology to brain imaging and cognitive neuroscience to big data and artificial intelligence.

• Brain Tumour
• Cognitive Neuroscience
• Epilepsy
• Neural Circuits
• Neurodegenerative Disorders
• Neurodevelopmental Disorders
• Neuroimaging and Neuroinformatics
• Neuroimmunological Diseases
• Rare Neurological Diseases

For more information, please visit mcgill.ca/neuro.

• 740 Doctor Penfield Avenue
• Montreal QC H3A 0G1
• Telephone: 514-398-3311
• Email: info.genome [at] mcgill.ca

不良研究所 has long been a leader in Canada and internationally in the increasingly vital fields of RNA, DNA, and other genomics research. In concert with the Faculty of Medicine and Health Sciences and affiliated hospitals within the 不良研究所 Health Centre, the newly created institute aims to maximize opportunities to apply genomics for clinical interventions in high-priority fields where 不良研究所 is already an established leader鈥攕uch as cancer, neuroscience and mental health, chronic inflammatory diseases and infectious diseases, including COVID-19.

By harnessing the interdisciplinary expertise and research infrastructure across 不良研究所鈥檚 faculties, the Institute seeks to implement a full spectrum approach to genomic medicine, which draws on information from a person鈥檚 genes and how they interact to inform an individual鈥檚 clinical care. 不良研究所 researchers will work to lead breakthrough research aimed at the development of cutting-edge diagnostic tools, targeted treatments, and new pharmaceuticals and preventative vaccines. Additionally, the Institute鈥檚 social sciences pillar will draw on expertise across the University to lead important research on the ethical, policy, and legal implications of genomic medicine.